Stoneridge (SRI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Outperformed weighted average end markets by 490 basis points in 2024, driven by strong growth in MirrorEye/Mirai and Smart 2 tachograph, despite a 10.4% market decline.
Achieved $23.8 million in free cash flow, a $55.5 million year-over-year improvement, supported by a $36.4 million inventory reduction.
Focused on cost control, manufacturing efficiency, and inventory management, resulting in improved cost structure and positive free cash flow.
2024 sales reached $908.3 million, with a net loss of $16.5 million and adjusted EBITDA of $37.9 million (4.2% of sales).
Long-term targets include $1.3–$1.45 billion revenue and $160–$200 million EBITDA by 2029.
Financial highlights
Full year 2024 sales were $908.3 million; gross margin was 20.9% and adjusted EBITDA margin was 4.2%.
Free cash flow improved to $23.8 million, up $55.5 million from 2023, driven by a $36.4 million inventory reduction.
Adjusted net loss was $13.1 million; adjusted EPS was $(0.47).
Control Devices sales declined 14% to $296.3 million, while Electronics sales were flat at $594.7 million, outperforming end markets by 16.3%.
Stoneridge Brazil sales were $50.3 million, with a 500 basis point margin decline due to macroeconomic challenges.
Outlook and guidance
2025 sales guidance is $860–$890 million (midpoint $875 million), with gross margin expected to improve by 135 basis points to 22.25%.
EBITDA margin targeted at 4.6% ($40 million midpoint), and free cash flow guidance of $25–$30 million.
MirrorEye/Mirai revenue expected to nearly double to $120 million in 2025, offset by $41 million in program roll-offs.
2026 revenue targeted at $975 million (11% growth), with EBITDA of at least $70 million (7% margin); long-term targets: $1.3–$1.45 billion revenue and $160–$200 million EBITDA by 2029.
Compliance leverage ratio expected between 2 and 2.5 times by end of 2025.
Latest events from Stoneridge
- 2025 outperformed end markets with 69%–70% MirrorEye growth and strong 2026 targets.SRI
Q4 202512 Mar 2026 - Q2 2024 saw margin gains, EPS growth, and updated guidance as key tech launches accelerated.SRI
Q2 20242 Feb 2026 - Control Devices sold for $59M to focus on advanced electronics and reduce debt.SRI
Status update2 Feb 2026 - MirrorEye and Smart 2 drive growth through innovation, safety, and regulatory compliance.SRI
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales and earnings declined, but cash flow and MirrorEye adoption showed improvement.SRI
Q3 202417 Jan 2026 - Growth driven by MirrorEye, Smart 2, and operational improvements despite market softness.SRI
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Margin gains and record product sales drive Q1, with guidance reaffirmed despite net loss.SRI
Q1 202524 Dec 2025 - 2025 proxy covers director elections, auditor ratification, compensation, and new LTIP.SRI
Proxy Filing2 Dec 2025 - Shareholders to vote on a new incentive plan consolidating all future equity awards.SRI
Proxy Filing2 Dec 2025